351 related articles for article (PubMed ID: 29251996)
1. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists.
Lewis JS; Beadle B; Bishop JA; Chernock RD; Colasacco C; Lacchetti C; Moncur JT; Rocco JW; Schwartz MR; Seethala RR; Thomas NE; Westra WH; Faquin WC
Arch Pathol Lab Med; 2018 May; 142(5):559-597. PubMed ID: 29251996
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.
Fakhry C; Lacchetti C; Rooper LM; Jordan RC; Rischin D; Sturgis EM; Bell D; Lingen MW; Harichand-Herdt S; Thibo J; Zevallos J; Perez-Ordonez B
J Clin Oncol; 2018 Nov; 36(31):3152-3161. PubMed ID: 30188786
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma: Impact of the 2018 College of American Pathologists Guideline Among Referral Cases at a Large Academic Institution.
Ferguson DC; Mehrad M; Ely KA; Shinn JR; Lewis JS
Arch Pathol Lab Med; 2021 Sep; 145(9):1123-1131. PubMed ID: 33373453
[TBL] [Abstract][Full Text] [Related]
4. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Bishop JA; Lewis JS; Rocco JW; Faquin WC
Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations.
Daneshpajouhnejad P; Miller JA; Maleki Z
Cytopathology; 2020 Nov; 31(6):547-554. PubMed ID: 32735747
[TBL] [Abstract][Full Text] [Related]
6. High-risk human papillomavirus testing in cytology aspiration samples from the head and neck part 1: a review of the literature on available testing options.
Manucha V; Adeniran AJ; Asiry S; Hoda RS; Johnson DN; van Zante A; VandenBussche CJ; Griffith CC;
J Am Soc Cytopathol; 2022; 11(5):295-305. PubMed ID: 35810109
[TBL] [Abstract][Full Text] [Related]
7. Current Perspective on HPV-Associated Oropharyngeal Carcinomas and the Role of p16 as a Surrogate Marker of High-Risk HPV.
Gurín D; Slávik M; Shatokhina T; Kazda T; Šána J; Slabý O; Hermanová M
Klin Onkol; 2019; 32(4):252-260. PubMed ID: 31426640
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma at One of the Largest Tertiary Care Centers in Sub-Saharan Africa.
Dapaah G; Hille J; Faquin WC; Whittaker J; Dittrich CM; Ebrahim AK; Schneider JW; van Wyk AC; Opperman J; Merven M; Naidoo K; Loock JW; Afrogheh AH
Arch Pathol Lab Med; 2022 Aug; 146(8):1018-1023. PubMed ID: 34871360
[TBL] [Abstract][Full Text] [Related]
9. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
Song SJ; Jalaly JB
Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
[TBL] [Abstract][Full Text] [Related]
10. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
11. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
12. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
13. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
14. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort.
Shinn JR; Davis SJ; Lang-Kuhs KA; Rohde S; Wang X; Liu P; Dupont WD; Plummer D; Thorstad WL; Chernock RD; Mehrad M; Lewis JS
Am J Surg Pathol; 2021 Jul; 45(7):951-961. PubMed ID: 33739785
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma in 2020: Where Are We Now and Where Are We Going?
Lewis JS
Head Neck Pathol; 2020 Jun; 14(2):321-329. PubMed ID: 32124415
[TBL] [Abstract][Full Text] [Related]
19. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
[TBL] [Abstract][Full Text] [Related]
20. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
